Introduction
Assessment of Genetics Laboratories Offering Family Analysis Services for VUS Classification
Lab Name and Family Studies Program* | Is there a Family Studies Program? What is a brief description? | What is the cost to patients and/or relatives? | How do you select the families for follow/up? Is every patient who is given a VUS in a cancer gene offered participation in family studies? | How long have you offered Family Studies? | What is the application process? |
---|---|---|---|---|---|
Ambry Genetics “Family Studies Program” http://www.ambrygen.com/family-studies-program
| Yes. The cases approved for family studies are those that will be most informative in the variant classification process. The decision to approve or deny family studies occurs in the context of the particular variant and family; therefore, all cases are encouraged to apply (with the exception of the moderate penetrance genes listed below). | No charge if accepted into family studies program | It is an application process. Certain genes are excluded from the family studies program: At this point in time, patient’s whose results consist of only one VUS in the following genes are not eligible for Ambry’s Family Study Program: ATM, BARD1, BRIP1, CHEK2, MRE11A, NBN, RAD50, RAD51C, and RAD51D. When applications are received for patients with one VUS in these genes, the provider will be informed about the Inherited Breast and Ovarian Cancer Study at Mayo Clinic. Providers may refer their patients to this study directly without applying to Ambry’s Family Study Program. Individuals with two VUS in the same gene from this list are still eligible to apply to the Family Studies Program for the purpose of determining phase (cis/trans). | 4 years or so but probably longer | There is a note put in the report if eligible for family studies with contact information on how to apply. Download forms and follow application process on website; it’s a patient application process. |
ARUP “FAMS” program | Yes. A family studies program is in place via the University of Utah IRB approved FAMS research study. Every VUS report has a note to please contact a GC to assess possibility of family studies. Once appropriate relatives are identified, consents and kits are sent to everyone. | No charge through a research study | Application process. No real exclusionary /inclusionary criteria. No genes excluded from family studies research. | At least 10 years | Every report of a VUS has an addendum that asks to please contact a GC at ARUP to ask about feasibility of family studies |
Baylor | There is not necessarily a “family studies” program in place, rather, individual cases reviewed on a case-by-case basis. | No charge for VUS in appropriate relatives if meets criteria | Case by case basis to see if appropriate. No set exclusion/inclusion criteria, cases are reviewed and deemed appropriate as they come in | At least 10 years, ever since cancer testing offered | Statement put in report if patient good candidate. |
Counsyl | Yes. Counsyl has been doing BRCA1/2 since 2013 and recently launched cancer panels in June 2015. There has been a family studies process in place at the lab. | No charge for eligible relatives | Patients/providers who get a VUS result are asked for a copy of a 3-generation pedigree. It is reviewed and if eligible GC is contacted. At this point, no gene exclusions for family studies, if gene is offer it on Counsyl’s panels. There is a “get counsyl” option which features on demand genetic counseling and coordinating. This can be helpful for coordinating family studies, shipping kits and arranging blood draws for other relatives. | For BRCA1/2 since 2013. Most VUS to date have been in these genes, recently launched panels. | Patients/providers who get a VUS result are asked for a copy of a 3-generation pedigree. It is reviewed and if eligible, GC is contacted. Counsyl gives “opt -out” option for VUS to provider so not all providers receive VUS results. |
Fulgent | Yes. Fulgent Diagnostics offers no-charge testing for qualifying relatives where a VUS has been reported by Fulgent. | No charge for eligible relatives | GC or care provider reaches out to Fulgent and they will work with patient/family on case-by-case basis. No set inclusion/exclusion criteria per say. | Since late 2013, since launching cancer genes | GC must contact Fulgent with information about the family (who is affected, and who is available for testing) to see if patient qualifies. Family study availability is not noted on test results. |
GeneDX “Variant Testing Program” | Yes. There is family studies/variant testing program in place. | No charge for eligible relatives | There are no set inclusion or exclusion criteria. Reviewed on case-by-case process. Any gene they offer can potentially be worked up in family studies. | Since August 2013, since launching cancer genes | Provider gets VUS test result and it is up to provider to contact GeneDx if interested in Family Studies for variant reclassification. Provider can submit pedigree and clinical information, GeneDx will let provider know if family is eligible for testing and if so, which individuals qualify for testing. |
Invitae “VUS Resolution Program” https://www.invitae.com/en/vus-resolution
| Yes. In order to help resolve variants of uncertain significance (VUS), Invitae offers follow-up testing at no additional charge to select relatives of patients previously tested at Invitae. Variant reclassification relies on information gathered from multiple families. Participation may not result in an immediate reclassification, but can provide information that contributes to this process. If a variant is reclassified, Invitae will issue amended reports with the new interpretation to all individuals who have the variant. Invitae supports sharing our variant interpretations, and makes de-identified variant interpretations publicly available to the research and medical communities via the Clinvar and Clinvitae databases. | No charge for qualifying families. For Families that do not qualify for VUS resolution the cost is $200 per individual per gene in which a VUS was found. | Not all variants can be resolved with this kind of analysis, and not all relatives can provide informative data. Decisions about program eligibility are based on:The family structure, disease status, and clinical presentation of available individuals. The type of sequence change in question. The gene in which the VUS was identified. The inheritance pattern(s) and penetrance of the disease(s) associated with the gene. Some genes are not eligible. If eligible the original clinical report will include a statement recommending consideration of VUS resolution. | About 5 years | Statement put in report if patient good candidate for family studies. Patient application process is all online. Patients make an account that pulls in all patients tested information and builds online pedigree. |
Myriad “MyVision” Variant Classification Program | Segregation analysis is one of several variant classification techniques used. | No charge for select patients and relatives | Myriad Genetic Laboratories scientists will review the family history and determine if family testing could provide data useful for reclassification | Over 10 years. | Most patients receiving variant result will get a variant information sheet, and an invitation to participate in Variant Classification Program. Provider sends in clinical history form and pedigree. If accepted, Myriad will send invitation and kit to provider to pass on to patients |
Pathway Genomics “Family Studies Program”
| Yes. Pathway Genomics offers a complimentary Familial Studies Program to help understand the significance of these genetic changes, and how the patient and relatives may be affected. Not all patients will qualify for complimentary testing. | No charge for patients and relatives | Any report where a VUS is detected will include an application for the clinician and patient to complete. Once familial application is received, it is reviewed within two to three weeks to determine program eligibility. For eligible families instructions will be sent to the ordering clinician that indicate which relatives are authorized for testing. Additional relatives who decide to participate will receive a complimentary laboratory report for the specific change variant in question as well as an interpretation of the current clinical implication. | No information provided. | If a VUS is detected, the report includes family studies application. Applications are reviewed by Familial Studies Program. |
University of Washington http://depts.washington.edu/labweb/Divisions/MolDiag/MolDiagGen/
| Yes. Families are reviewed on a case-by-case basis during multiple-medical-director case review. Families may be eligible for family studies through the University of Washington Department of Laboratory Medicine or on a research basis through research laboratories. | No charge for select patients and relatives | Director and laboratory GC review families. Availability of family analysis for clinical follow-up may be communicated by phone or email to providers. Ordering providers may also contact the laboratory to query about eligibility. Families are evaluated to determine if available relatives are likely to provide sufficient evidence to reclassify the VUS. | 4 years | Provider must contact laboratory to discuss |
Assessment Results
Motivation to Develop General Online Resources for Family Based VUS Classification
FindMyVariant.org, a New Resource for VUS Family Studies
Module | Section | Content/Purpose |
---|---|---|
What Does VUS mean | What is a Genetic Variant | Explains variation in human disease and the different ways they are classified |
Genetic Variants & Disease | Variants can be associated with increased or decreased risk for disease | |
Understanding Rare Variants | Most rare variants are benign, and certain rare variants can be unique in families | |
Medical Care and VUS | Guidelines suggest not to alter medical management given a VUS, but rather, consider family history and other risk factors when assessing risk. | |
Reclassifying VUS | Sufficient evidence may determine if a VUS does or does not cause disease in the family and reclassification of the VUS to benign or likely pathogenic can occur. | |
Co-Segregation Analysis for Variant Classification | Information that can be used to classify a variant | This information includes, comparing variant to other variants, looking at how often this variant occurs in individuals with disease, comparing this variant across species |
Basics of using family information for co-segregation analysis: | Describes methods and likelihood ratios used when performing family studies to determine if a variant is associated with disease | |
Evidence standards for variant classification | Reviews different levels of classification assigned to variants ranging from benign to pathogenic. | |
Classifying a pathogenic variant | Provides description and illustration of a pedigree for a pathogenic variant at different sizes/stages of analysis | |
Classifying a benign variant | Provides description and illustration of a pedigree for a benign variant at different sizes/stages of analysis | |
Using other information to help classify a variant | How geneticists can compile many sources of information to determine a likelihood ration that a variant is traveling with disease in a family. | |
Talking with your immediate family about your variant | Start with what you already know | Instructs individuals to start by recording pertinent personal information |
Organize information about your immediate family | Teaches how to add known family history information about close relatives | |
Add what you know about your extended family | Describes adding information about health and disease in extended family members | |
Talking with your family | Instruct how to be sensitive to family members while communicating with them. | |
Contact your living parents and siblings | Explains how to collect, record, and confirm basic facts about close relatives. | |
Using genealogy to identify ancestors who might have your variant | Talking with living relatives to find your ancestors | Teaches how to gather information from living relatives about deceased ancestors. |
Using online genealogy tools to find your ancestors | Lists several genealogy resources including major family history websites with a very brief description of how to use these resources. | |
Obtaining tumors from deceased ancestors for testing | Introduces the potential option of getting tissue from pathology samples from deceased ancestors and briefly describes this process. | |
Finding and Connecting with distant relatives that might have your variant | Start with the people you know | Explains that the best way to find distant relatives is by starting with people that you already know |
Talking with living relatives to find descendants of your ancestors | Describes how to talk to known relatives about descendants of a common ancestor, including how to ask for contact information of distant relatives. | |
Using online social networking sites to find descendants of your ancestors | Provides examples of how to use social networking sits, like Facebook, to identify distant relatives. | |
Don’t forget low-tech | Lists several public search engines used for finding information about relatives and a variety of people search tools. | |
Laboratory Testing and asking relatives about participation in VUS classification | Finding a clinical Laboratory to Test Samples and Classify Your Variant | Lists family study resources offered by several clinical laboratories in the United States. |
Finding a Research Laboratory to Test Samples and Classify Your Variant | Lists contact information for research studies performing family studies for VUS reclassification. | |
Asking Family Members to Help You Classify Your VUS | Different clinical laboratories and research studies have different processes for sample submission. This module instructs participants to contact the testing laboratory directly to find details about how relatives can submit samples and offers tips for approaching family. | |
Example Scripts to Ask a Family Member to Help Classify a Variant | Provides text examples of how to ask a family member to donate a sample to help classify a VUS. | |
Genetics Education | What is a gene? | Lists websites that provides explanations and resources for genetics learning tools |
What is a variant? | Lists websites that explain normal variation across humans and provides links learning tools | |
Where do our genes come from? | Lists websites that explain basic concepts of heredity and de novo mutations | |
How does heredity work? | Lists websites that describe inheritance patterns in families and individuals | |
What is a mutation? | Lists websites that describe what changes in DNA are and how they happen. |